Combating Complement's Deleterious Effects on Nanomedicine by Conjugating Complement Regulatory Proteins to Nanoparticles

Abstract

Complement opsonization is among the biggest challenges facing nanomedicine. Nearly instantly after injection into blood, nanoparticles are opsonized by the complement protein C3, leading to clearance by phagocytes, fouling of targeting moieties, and release of anaphylatoxins. While surface polymers such as poly(ethylene glycol) (PEG) partially decrease complement opsonization, most nanoparticles still suffer from extensive complement opsonization, especially when linked to targeting moieties. To ameliorate the deleterious effects of complement, two of mammals’ natural regulators of complement activation (RCAs), Factors H and I, are here conjugated to the surface of nanoparticles. In vitro, Factor H or I conjugation to PEG‐coated nanoparticles decrease their C3 opsonization, and markedly reduce nanoparticle uptake by phagocytes. In an in vivo mouse model of sepsis‐induced lung injury, Factor I conjugation abrogates nanoparticle uptake by intravascular phagocytes in the lungs, allowing the blood concentration of the nanoparticle to remain elevated much longer. For nanoparticles targeted to the lung's endothelium by conjugation to anti‐ICAM antibodies, Factor I conjugation shifts the cell‐type distribution away from phagocytes and toward endothelial cells. Finally, Factor I conjugation abrogates the severe anaphylactoid responses common to many nanoparticles, preventing systemic capillary leak and preserving blood flow to visceral organs and the brain. Thus, conjugation of RCAs, like Factor I, to nanoparticles is likely to help in nanomedicine's long battle against complement, improving several key parameters critical for clinical success.

Evolution of complexity in non-viral oligonucleotide delivery systems: from gymnotic delivery through bioconjugates to biomimetic nanoparticles

“…Another strategy is to conjugate immunomodulators e.g. regulators of complement activation that down-regulate complement response[ 26 ]. Despite the progress, some therapies require frequent administration of the RNA drug which increases the chance to develop allergic reactions.…”

Brain Tumor Cell Membrane‐Coated Lanthanide‐Doped Nanoparticles for NIR‐IIb Luminescence Imaging and Surgical Navigation of Glioma

“…[18][19][20] However, the BBB-crossing efficiency is always impaired by rapid blood clearance and the weak binding ability between the ligands and receptors. [21] Recently, cell membrane-coated nanoparticles prepared by translocating the entire membrane from a cell onto the surface of nanoparticles have attracted considerable attention due to their capability of replicating the highly complex cell membrane functionalities. [22] A variety of cell membrane-coated nanoparticles have been developed, which possess various functions such as evading immune clearance, [23] prolonging circulation time, [24] and targeting disease sites.…”

Targeted In Vivo Loading of Red Blood Cells Markedly Prolongs Nanocarrier Circulation

“…or via mimicking natural pathways inhibiting immune recognition and clearance (Factor I, CD47, etc. ). − …”